Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosalie Lubbers

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Scientific Reports|April 15, 2020
Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosisKarin Dijkman, Rosalie Lubbers, Nicole V Borggreven, et al.
European Journal of Immunology|January 29, 2022
Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cellsMieke F van Essen, Nicole Schlagwein, Elisa M P van den Hoven, et al.
Molecular Immunology|March 18, 2020
Expression and production of the SERPING1-encoded endogenous complement regulator C1-inhibitor in multiple cohorts of tuberculosis patientsRosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
Nature Communications|July 8, 2018
Genetic deficiency of NOD2 confers resistance to invasive aspergillosisMark S Gresnigt, Cristina Cunha, Martin Jaeger, et al.
Frontiers in Immunology|November 9, 2018
Complement Component C1q as Serum Biomarker to Detect Active TuberculosisRosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Scientific Reports|April 15, 2020
Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosisKarin Dijkman, Rosalie Lubbers, Nicole V Borggreven, et al.
European Journal of Immunology|January 29, 2022
Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cellsMieke F van Essen, Nicole Schlagwein, Elisa M P van den Hoven, et al.
Molecular Immunology|March 18, 2020
Expression and production of the SERPING1-encoded endogenous complement regulator C1-inhibitor in multiple cohorts of tuberculosis patientsRosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
Nature Communications|July 8, 2018
Genetic deficiency of NOD2 confers resistance to invasive aspergillosisMark S Gresnigt, Cristina Cunha, Martin Jaeger, et al.
Frontiers in Immunology|November 9, 2018
Complement Component C1q as Serum Biomarker to Detect Active TuberculosisRosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
Pageof 1